Chemistry and pharma Why the AI drug revolution has yet to deliver Speed, safety and smarter molecules have yet to translate into better medicines reaching patients. The real breakthrough may come from rethinking what we ask AI to do in the lab, writes Robert Roe Latest Content UK consortium to help accelerate adoption of low carbon medicinal manufacturing ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026 Why the AI drug revolution has yet to deliver New technologies QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research White papers Protecting bioanalytical data integrity from bench to report Discover how Thermo Scientific™ Watson™ LIMS software safeguards data integrity in bioanalytical studies through traceability, compliance, and automation, reducing regulatory risk and enhancing productivity across the entire bioanalytical process. Future-proofing your lab: key considerations for upgrading or switching chromatography data systems This White Paper guides you in determining whether upgrading your existing system is sufficient or if transitioning to a new CDS is the better, future-ready option. Centralising analytical data from mass spectrometry in drug discovery and development Discover how experts from Zoetis, Bayer, LifeMine Therapeutics, Iterion, Targenomix, and the Pistoia Alliance are solving key data challenges for mass spectrometry applications. Webcasts On Demand: Free Online Panel Discussion | LIMS innovation boosts precision and security Free Energy Perturbation: How Computational Chemistry Saves Time In Drug Discovery More content Westcott Space Hub opens to boost UK space innovation and create hundreds of jobs The key to effective chemical R&D workflow automation: putting in-house experts in control Optibrium aims to solve real-world efficiency and productivity challenges using AI ODD announces further validation of novel oncology therapeutic mechanism Quantum computing platform beats AI in drug discovery, study claims Revvity introduces Signals Xynthetica, an AI-augmented design platform for molecular and materials discovery Unifying acquisitions under one Instem brand IDBS celebrates customer successes and product innovations in 2025 Beyond generic LIMS: how specialised software enhances bioanalytical labs Revvity acquires ACD/Labs Protecting bioanalytical data integrity from bench to report Quantum computing project by UCD spin-out secures €13.7m funding Pagination Previous page ‹ Previous Page 2 Next page Next ›
